Processa Pharmaceuticals Statistics
Total Valuation
PCSA has a market cap or net worth of $5.40 million. The enterprise value is $2.53 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, after market close.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PCSA has 26.19 million shares outstanding. The number of shares has increased by 193.57% in one year.
Current Share Class | 26.19M |
Shares Outstanding | 26.19M |
Shares Change (YoY) | +193.57% |
Shares Change (QoQ) | +171.43% |
Owned by Insiders (%) | 1.75% |
Owned by Institutions (%) | 2.65% |
Float | 20.92M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.31 |
P/TBV Ratio | 1.53 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.01.
Current Ratio | 2.93 |
Quick Ratio | 2.26 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -192.72% and return on invested capital (ROIC) is -119.93%.
Return on Equity (ROE) | -192.72% |
Return on Assets (ROA) | -102.42% |
Return on Invested Capital (ROIC) | -119.93% |
Return on Capital Employed (ROCE) | -342.78% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.20M |
Employee Count | 10 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.59% in the last 52 weeks. The beta is 1.29, so PCSA's price volatility has been higher than the market average.
Beta (5Y) | 1.29 |
52-Week Price Change | -88.59% |
50-Day Moving Average | 0.26 |
200-Day Moving Average | 0.66 |
Relative Strength Index (RSI) | 43.13 |
Average Volume (20 Days) | 48,219,550 |
Short Selling Information
The latest short interest is 859,990, so 3.28% of the outstanding shares have been sold short.
Short Interest | 859,990 |
Short Previous Month | 528,407 |
Short % of Shares Out | 3.28% |
Short % of Float | 4.11% |
Short Ratio (days to cover) | 0.10 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -12.09M |
Pretax Income | -9.83M |
Net Income | -11.96M |
EBITDA | -12.09M |
EBIT | -12.09M |
Earnings Per Share (EPS) | -$2.48 |
Full Income Statement Balance Sheet
The company has $2.90 million in cash and $49,659 in debt, giving a net cash position of $2.85 million or $0.11 per share.
Cash & Cash Equivalents | 2.90M |
Total Debt | 49,659 |
Net Cash | 2.85M |
Net Cash Per Share | $0.11 |
Equity (Book Value) | 3.53M |
Book Value Per Share | 0.67 |
Working Capital | 2.47M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$11.93 million and capital expenditures -$3,244, giving a free cash flow of -$11.93 million.
Operating Cash Flow | -11.93M |
Capital Expenditures | -3,244 |
Free Cash Flow | -11.93M |
FCF Per Share | -$0.46 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PCSA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -193.57% |
Shareholder Yield | -193.57% |
Earnings Yield | -222.26% |
FCF Yield | -221.72% |
Analyst Forecast
The average price target for PCSA is $2.00, which is 869.87% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $2.00 |
Price Target Difference | 869.87% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on January 22, 2024. It was a reverse split with a ratio of 0.05:1.
Last Split Date | Jan 22, 2024 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |